These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18640726)

  • 1. Characterisation of soluble murine CD137 and its association with systemic lupus.
    Shao Z; Sun F; Koh DR; Schwarz H
    Mol Immunol; 2008 Sep; 45(15):3990-9. PubMed ID: 18640726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
    Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
    Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo.
    Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS
    Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
    Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
    Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
    Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W
    J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes.
    Michel J; Schwarz H
    Cytokine; 2000 Jun; 12(6):742-6. PubMed ID: 10843756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.
    Dongming L; Zuxun L; Liangjie X; Biao W; Ping Y
    Clin Chim Acta; 2010 Mar; 411(5-6):406-10. PubMed ID: 20026323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation.
    Shin SM; Kim YH; Choi BK; Kwon PM; Lee HW; Kwon BS
    J Leukoc Biol; 2007 Jun; 81(6):1455-65. PubMed ID: 17389581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
    Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
    Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
    Olofsson PS; Söderström LA; Wågsäter D; Sheikine Y; Ocaya P; Lang F; Rabu C; Chen L; Rudling M; Aukrust P; Hedin U; Paulsson-Berne G; Sirsjö A; Hansson GK
    Circulation; 2008 Mar; 117(10):1292-301. PubMed ID: 18285570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
    Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
    Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking of 4-1BB up-regulates IL-13 expression in CD8(+) T lymphocytes.
    Nam KO; Shin SM; Lee HW
    Cytokine; 2006 Jan; 33(2):87-94. PubMed ID: 16488622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD137 ligand signaling enhances myelopoiesis during infections.
    Tang Q; Jiang D; Alonso S; Pant A; Martínez Gómez JM; Kemeny DM; Chen L; Schwarz H
    Eur J Immunol; 2013 Jun; 43(6):1555-67. PubMed ID: 23519951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes.
    Palazón A; Teijeira A; Martínez-Forero I; Hervás-Stubbs S; Roncal C; Peñuelas I; Dubrot J; Morales-Kastresana A; Pérez-Gracia JL; Ochoa MC; Ochoa-Callejero L; Martínez A; Luque A; Dinchuk J; Rouzaut A; Jure-Kunkel M; Melero I
    Cancer Res; 2011 Feb; 71(3):801-11. PubMed ID: 21266358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of membrane TNF-alpha on activated peripheral CD8+ T cells in systemic lupus erythematosus.
    Horiuchi T; Morita C; Tsukamoto H; Mitoma H; Sawabe T; Harashima S; Kashiwagi Y; Okamura S
    Int J Mol Med; 2006 May; 17(5):875-9. PubMed ID: 16596274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling.
    Jiang D; Yue PS; Drenkard D; Schwarz H
    Stem Cells; 2008 Sep; 26(9):2372-81. PubMed ID: 18566330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.
    Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB
    Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death.
    Atsumi T; Sato M; Kamimura D; Moroi A; Iwakura Y; Betz UA; Yoshimura A; Nishihara M; Hirano T; Murakami M
    Int Immunol; 2009 Jan; 21(1):73-80. PubMed ID: 19050105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.